THIRD HARMONIC BIO INC (THRD) Stock Analyst Ratings
NASDAQ:THRD - Nasdaq - US88427A1079 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 76% to THRD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.67. This target is -10.05% below the current price.
THRD was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about THRD.
In the previous month the buy percentage consensus was at a similar level.
THRD was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-28 | Stifel | Downgrade | Buy -> Hold |
| 2025-02-12 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2025-02-11 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2024-08-09 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2024-06-18 | Stifel | Initiate | Buy |
| 2024-06-07 | Raymond James | Initiate | Outperform |
| 2023-08-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2022-12-16 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-12-16 | Jefferies | Downgrade | Buy -> Hold |
| 2022-10-10 | Cowen & Co. | Initiate | Outperform |
| 2022-10-10 | Morgan Stanley | Initiate | Overweight |
| 2022-10-10 | Jefferies | Initiate | Buy |